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Biodegradable magnesium (Mg) alloys combine the advantages of traditional metallic implants and biodegrad-
able polymers, having high strength, low density, and a stiffness ideal for bone fracture ﬁxation. A recently devel-
oped Mg–Ca–Sr alloy potentially possesses advantageous characteristics over other Mg alloys, such as slower
degradation rates andminimal toxicity. In this study, the biocompatibility of this Mg–Ca–Sr alloy was investigat-
ed in a rat pin-placement model. Cylindrical pins were inserted in the proximal tibial metaphyses in pre-drilled
holes orthogonal to the tibial axis. Implant and bone morphologies were investigated using μCT at 1, 3, and
6 weeks after implant placement. At the same time points, the surrounding tissue was evaluated using H&E,
TRAP and Goldner's trichrome staining. Although gas bubbles were observed around the degrading implant at
early time points, the bone remained intact with no evidence of microfracture. Principle ﬁndings also include
new bone formation in the area of the implant, suggesting that the alloy is a promising candidate for biodegrad-
able orthopedic implants.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Research on biodegradable magnesium (Mg) alloys is steadily in-
creasing due to their potential to replace currently used fracture ﬁxation
devices [1]. Degradable implants eliminate the need for removal surger-
ies, which are often required for permanent metallic implants such as
titanium, stainless steels, and cobalt–chromium alloys [2,3]. Metallic
implants can also corrode or release toxic wear products, leading to
hostile local or systemic reactions [2,4]. Although biodegradable
polymers, such as poly-lactic acid (PLA) or poly-glycolic acid (PGA), are
frequently used clinically, thesematerials are limited in their applications
by their relatively low strength compared to traditional metallic implants
[5]. Polymeric devicesmay leave polymeric debris, which can lead to local
inﬂammatory responses and implant loosening [5–8]. Another
unfortunate consequence of the use of these polymeric materials, espe-
cially those based on PLA, is the long degradation time resulting in
foreign-body reactions after implantation [5,8,9]. Magnesium, on the
other hand, degrades rapidly, has a low density, and is generally consid-
ered biocompatible.Moreover,Mghas stiffness similar to that of bone, po-
tentially reducing the risk of stress shielding effects that can occur with
traditional metallic implants [2,10,11]. Mg also has high strength relative
to polymericmaterials and could thereby support load bearing structures,
potentiallymaking it ideal for resorbable implants placed into bone. How-
ever, controlling the degradation rate of Mg remains a challenge. This is
crucial in implant applications since hydrogen gas evolved during degra-
dation can compromise the mechanical support required for fracture
healing processes, while rapid degradation also affects themechanical in-
tegrity of the implant. Although surface treatments and coatings can slow
the initial rate of degradation, these processes are often complicated and
expensive [12], making alloying a more practical option. Among various
systems previously studied, Mg–Ca alloys have shown attractive re-
sponses, including improved degradation behavior and biocompatibility
[13–15]. Recently, our research group and others have been exploring
the potential to create implants based onMg–Ca–Sr [16,17].Mg–Ca–Sr al-
loys have shown reduced degradation rates compared to cast binaryMg–
Ca and Mg–Sr alloys with similar alloying amount [13,18]. In addition, Sr
may assist in the bone healing process. Administration of Sr, either as a
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dietary supplement in the formof salts [19–21] orwhen incorporated into
implant material [22–24], has shown to promote osteoblast proliferation
and improve osseointegration. While preliminary in vitro testing on this
ternary Mg–Ca–Sr alloy has conﬁrmed reduced degradation rates
compared to binary alloys, and non-cytotoxic responses in osteoblastic
cell cultures [16], the in vivo response is unknown.Understanding the bio-
degradation performance of Mg-Ca-Sr alloys and their effect on
surrounding tissue is crucial for future design and optimization. The
objective of the current study is to assess the local tissue response when
Mg–1.0 wt.%Ca–0.5 wt.%Sr alloy is implanted into the rat tibia.
2. Materials and methods
2.1. Alloy preparation
CylindricalMg–1.0wt.%Ca–0.5wt.%Sr alloy pinsmachined from as-
castmaterialwere used as implants [16]. Cast sampleswere cut using a
low-speed diamond saw, followed bymachining down to a 0.8mmdi-
ameter smooth surface using a lathe. The cutting and machining
processes were performed using oil-based lubricants. Alloy pins were
cleaned in soap and ethanol and sterilized in an ethylene oxide gas
chamber prior to implantation.
2.2. Experimental design
24 adult male Sprague–Dawley rats with a bodyweight of 250–300 g
were randomly divided into ﬁve groups: Mg pin at 1 week (n = 4),
Mg pin at 3 weeks (n = 4), Mg pin at 6 weeks (n = 6), poly-L-lactic
(PLLA) pin at 6 weeks (n = 6), and naïve healthy controls (n = 4).
Because PLLA and Mg were only compared at the ﬁnal time point, a
higher sample number at 6weekswas used to provide amore robust es-
timate of themean and standarddeviation of both groups. CylindricalMg
alloy pins had a diameter of 0.8mm (as described above). Biodegradable
PLLA pins with a diameter of 1.1 mm were obtained commercially
(SmartPin®, Conmed Linvatec, Largo, FL) and used for qualitative
comparison. All animal work was approved by the University of Florida
Institutional Animal Care and Use Committee and conforms to the
AAALAC and NIH ethical guidelines for animal research. In accordance
with IACUC-approved humane endpoints, one rat in the PLLA pin
group was humanely euthanatized due to unanticipated complications
during surgery; these complications were unrelated to the pin. One
sample from the Mg-1w group was excluded from μCT analysis and
quantitative histological evaluation due to inadequate placement discov-
ered during post-processing. One pin in the Mg-1w group was found to
be fractured upon dissection, but the sample was included in the analy-
ses as the time of fracture was not known (placement, post-placement,
vs dissection).
2.3. Surgical procedure
Rats were anesthetized in an isoﬂurane sleep box (2–5%), then
transferred to a sterile ﬁeld with isoﬂurane maintained at 1–2% via
mask inhalation. A medial approach to the proximal tibia was made
using a combination of sharp and blunt dissection. A transverse pilot
Fig. 2. Representative 3D reconstructions of the implant morphology and the calculated implant volume at different time points. The dashed line in the graph denotes the initial pin vol-
ume. The 6w implant volume is signiﬁcantly smaller compared to 1w (p = 0.028) and 3w (p = 0.014), as indicated by *.
Fig. 1. μCT images showing how pixel distances from the implant boundary are determined, as used in BIC measurements.
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hole was made using a 0.8 mm diameter Kirschner wire frommedial to
lateral in the proximal tibial metaphysis medial to the tibial tuberosity.
The biodegradable pin was placed by hand into the pilot hole using a
small Jacobs Chuck. Following insertion, the pin was cut at the tibial
cortical surface. The subcutaneous layer was closed with 5-0 PDS, and
the skin was closed with skin wound clips; wound clips were removed
at 14 days post-operation. Buprenorphine was provided intra-
operatively and twice a day for 48 h to manage post-operative pain. The
animals were allowed to move freely in their cages post-operation and
were monitored daily for body-condition score [25], signs of edema at
the surgical site, and a visual assessment of animal mobility. No adverse
events were noted. At the predeﬁned time points listed above, animals
were humanely euthanized; then, soft tissue was carefully dissected and
bone was ﬁxed in neutral buffered 10% formalin solution for 48 h, trans-
ferred to gauze soaked with phosphate buffered saline, and frozen at
−20 °C.
2.4. μCT analyses
The disarticulated tibia was placed in a vial and immersed in
saline. Samples were scanned using a Skyscan 1172 μCT system
(Bruker Corporation, Billerica, MA) at its maximum resolution of
10.05 μm voxel size. The system was operated using the following
settings: 60 kV, 133 μA, 0.7° rotation step, 4 frame average,
2240 × 2240 CCD and 700 ms exposure. Scan time was 20 min per
sample. For implantmorphology and bone intersection surfacemeasure-
ments, the trans-axial plane of the implant was analyzed. A user-
determined implant boundary was created because gray-scale value
similarities between the implant and surrounding tissue limited an
automated approach. The fraction of bone in the vicinity of the degrading
implant was measured. The approach was similar to the bone implant
contact (BIC) method commonly used for permanent implant to
determine osseointegration by measuring the bone intersection surface
area at the implant boundary. Due to the nature of the degrading
implant, the bone intersection surface area was instead analyzed at 12,
20 and 28 pixels from the receding implant boundary. A schematic of
these distances are shown in Fig. 1. Bone morphology and mineral
density were analyzed in the trans-axial plane of the tibia. The volume
of interest (VOI) was 8 mm long and centered on the implant. Due to
irregular callus formation, two different thresholds were used, one for
the high-density cortical bone and a lower threshold for the lower
density bone forming as part of the fracture healing process. Bone densi-
ty measurement was performed on all samples that received alloy pins,
and on controls, by analyzing the entire tissue area (excluding voids).
Two hydroxyapatite (HA) phantoms with known density (0.25 and
0.75 gHA/cm3) and similar diameter to the rat tibias were used to
convert linear attenuation coefﬁcient to tissue mineral density. One
sample from the Mg-1w group was excluded from mineral density
measurements as the VOI extended too far proximally.
2.5. Histochemical staining
Calciﬁed sections were prepared by mounting in methyl methacry-
late (MMA, Sigma-Aldrich, St. Louis, MO) and cutting along the longitu-
dinal axis of the implant using a rotary microtome with a tungsten
carbide knife (4 μm thick sections). The remainders of alloy pins were
removed as part of this process. Sections from each tibia were stained
with hematoxylin and eosin (H&E) and Goldner's trichrome to study
cellularity and mineralization, respectively. Tartrate-resistant acid
phosphatase (TRAP) staining was conducted to study bone remodeling.
Histologic staining was carried out using standard procedures, with
samples qualitatively evaluated using light microscopy (Nikon Eclipse
TE2000-U, Nikon Instruments Inc., Melville, NY). The level of TRAP-
positive osteoclasts was determined using a computer-assisted
histomorphometry approach (MATLAB R2012b, The MathWorks Inc.,
Natick, MA). An area percentage was determined in each sample by
counting red-positive pixels in a radius of approximately 2mmcentered
on the implant. For each sample, a minimum of ﬁve images (10×
magniﬁcation) were analyzed from each quadrant around the pin
center.
2.6. Statistics
Statistical analyses were performed using one-way analysis of
variance (ANOVA) with Mann–Whitney post-hoc tests (α = 0.05,
Minitab 15, Minitab Inc., State College, PA). A non-parametric method
was chosen since the raw data appeared skewed. Mean ± 1 standard
deviation is shown in all ﬁgures unless otherwise speciﬁed.
Fig. 4. BIC area presented as the percentage of bone intersection surface at different dis-
tances from the alloy implant boundary at different time points. Statistically, there is no
signiﬁcant difference within any of the time point groups at the different pixel distances,
or within any of the pixel groups at the different time points.
Fig. 3. Representative 3D reconstructions showing the bone morphology around alloy implants at different time points. A 6w control and PLLA-6w are shown for comparison.
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3. Results
3.1. Initial biological response
All rats tolerated the implants well with only mild wound swelling
from surgery (b4 days) and no visible evidence of infection. No
incidences of limb disuse or lameness were noted in any group.
3.2. Degradation performance
Fig. 2 shows representative 3D reconstructions of the alloy pin at 1w,
3w, and 6w, respectively, along with the calculated average implant
volume. 2D area measurements and calculations of implant cross-
sectional area were also performed to complement the 3D calculations
since inherent VOI errors exist with 3D reconstructions. The implant
was almost completely degraded at 6w with less than 10% of the origi-
nal volume present, which is in accordance with the 2D calculations
(not shown). The remaining implant was located in, or adjacent to,
the cortical bone. Within the trabecular region, the implant appeared
to degrade uniformly. The PLLA pinwas intact and did not resorb during
the study period.
3.3. Bone morphology
Fig. 3 shows representative μCT 3D reconstructions of the bone sur-
rounding the implants at the different time points. Note that the PLLA
pin region appears smaller due to radiolucency of the implant and
thus an artifact of the imaging technique. As the alloy degraded, it was
consistently replaced by bone by the 6 w time point. To verify new
bone was replacing the degrading alloy implant, BIC measurements
were performed by calculating the bone area fraction at radial surfaces
from the implant boundary at each time point (Fig. 4). No BIC calcula-
tions were performed around PLLA pins due to its radiolucency and no
BIC information can be provided for the control sample, as the there is
no referencepoint (implant boundary) present fromwhere tomake cal-
culations. The average alloy implant radius at the different time points
were 0.40 mm (0w), 0.17 ± 0.21 mm (1w), 0.12 ± 0.11 mm (3w)
and 0.05 ± 0.02 mm (6w), respectively. For each sample, BIC increased
with increasing distance from the implant. BICmeasurements also show
no decrease in bone area in the proximity of the degrading implants
with time. As a reference point, the bone volumeper total tissue volume
(BV/TV) in the region of interest in the control samples is 90.7 ± 2.2%.
No decrease in bone area at ﬁxed distances from the decreasing implant
radius suggests that the bone fraction is increasing with time. Comple-
mentary, bone density measurements showed mineral density
increased with time, as depicted in Fig. 5.
3.4. Tissue response
3.4.1. Hydrogen gas formation
Histological indication of the gas resulting from the degradation
process of the alloys, as represented by voids, and the associated tissue
Fig. 6. Representative sections of rat tibia stained with Goldner's trichrome, at 1w (a), 3w (b) and 6w (c) post-surgery, and a 6w control (d), displaying possible gas accumulation in the
tissue surrounding the alloy implant, as shown by voids. Mineralized bone at the implantation site can be seen 6w post-surgery (c, circled).
Fig. 5. Average bone mineral density of the tissue in samples with alloy pins at different
time points (VOI 8 mm long, centered on the implant). Signiﬁcant differences are indicat-
ed by *. The 3w mineral density value is signiﬁcantly smaller compared to 6w (p =
0.0142) and control (p = 0.0304), and the 6w value is smaller compared to control
(p = 0.0252).
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response were seen at the 1w and 3w time points (Fig. 6). However,
voids were not observed at 6w, suggesting degradation is slower or
complete and gas was systemically absorbed. Despite gas accumulating
in the intramedullary cavity at early time points, no evidence of
microfracture in the bonewas found in either μCT images or histological
staining.
3.4.2. Histology
Overall, mild inﬂammatory response was noted. The 6w samples
showed normal morphology with cell proliferation and inﬁltration
into the implant site (Fig. 7). Some ﬁbroblast-like cells were observed
adjacent to the implant in all groups; however, a continuous ﬁbrous
capsule with thickness of 50–100 μm and with a dense population of
ﬁbroblast-like cells was observed around PLLA implants, indicative of
a foreign body response (Fig. 8). A ﬁbrous capsule was not observed at
any time point in the Mg alloy groups.
At all time points, bone remodeling was observed, as suggested by
the osteoblasts (blue/black) and osteoid (red) areas in Fig. 6 (Goldner's
stain), and the red-colored osteoclasts in Fig. 9 (TRAP stain). Mineral-
ized bone is shown in Fig. 6, as represented by blue–green color, and
newly non-mineralized areas, as represented by red. After 6w, the cor-
tical area at the implantation site was mineralized, showing minimal
remnant implant and smooth remodeling of cortical bone (Fig. 6). This
was observed in all Mg-6w samples, although to different extents.
Earlier time points had varied amounts of mineralization in the cortical
area. At all time points, scattered bone tissue formations were seen in
the medullary cavity.
3.4.3. Osteoclast quantiﬁcation
The average level of osteoclasts for each group is shown in Table 1.
The calculations were performed on micrographs similar to the ones
seen in Fig. 9. No signiﬁcant difference between different quadrants
were detected, but overall, larger amount of osteoclasts were observed
at the earlier time points (Mg-1w and Mg-3w) and in the PLLA
samples, with the largest amount seen in the Mg implant samples
after 3w. Osteoclasts were primarily located in the cortical region and
around tissue cavities. The amount of osteoclasts was signiﬁcantly
reduced at the 6w time point, suggesting the degrading implant was
well tolerated by the local tissue.
4. Discussion
Biodegradable Mg alloys attempt to combine the advantages of
traditional metallic implants and biodegradable polymers. Mitigating
gas production by slowing the degradation rate is one of the objectives
of alloying. While it is critical to prevent patient discomfort and main-
tain implant stability, a potentially fatal effect of rapid degradation can
occur if, for example, gas bubbles were to reach the vascular system.
In the development process of these materials, in vivo studies provide
crucial information on alloy degradation behavior and biocompatibility.
In this study, histological evidence suggests gas formation in the early
stages of alloy degradation, which correlates to the decrease in implant
volume. More rapid alloy degradation at the early stages is potentially
explained by an increased amount of ﬂuid in the cancellous tissue
from pin insertion as a result of tissue trauma or ﬂuid accumulation.
Faster alloy degradation in themarrow can be attributed to greater vas-
cularization of the cancellous bone, as has been observed and discussed
by other researchers [26–28]. A richer blood supply could remove deg-
radation products and neutralize the pH more rapidly, which increases
the degradation rate since an alkaline environment promotes a protec-
tive hydroxide layer that retards further degradation [29,30]. The gas
composition was not measured, but according to the electrochemical
reaction Mg + 2H2O→Mg(OH)2 + H2, the Mg-based pins degrade by
giving off hydrogen gas. The hydrogen is then exchanged with the
Fig. 8.H&E stained PLLA sample (6 w) showing the encapsulated implant (a, 1×)with amagniﬁcation of the ﬁbrous layer (b, 20×). b) is amagniﬁed image from the area inside of the box
highlighted in a).
Fig. 7.H&E stainedMg-6w sample showing bone resident cell inﬁltration at the implantation site at lowmagniﬁcation (a, 1×) and highermagniﬁcation (b, 20×). b) is a magniﬁed image
from the area inside of the box highlighted in a).
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environment [31], diffuses through the tissues and is eliminated by the
blood ﬂow and renal system [32]. If diffusion is slower than the gas
production, gas will accumulate in tissue cavities. The absence of voids
at 6w suggest that degradation slowed to allow for complete gas ab-
sorption by this time. Similar results have been observed in previous
studies on Mg alloys [13,32–34].
The thermodynamic predictions along with previous work in the
ﬁeld suggest that the layer forming on Mg alloys is Mg(OH)2 [30,35].
For the pins in the current study, it can be hypothesized that the Mg is
potentially substituted with small amounts of Ca and Sr. Mg(OH)2 is
considered safe in the body and has been suggested to comprise the
osteoconductive properties observed of Mg [36]. The Mg(OH)2 will
react to form soluble MgCl2, but its presence could be stabilized by
local accumulation of Mg-Ca phosphates [30,34]. The amount of Mg
and Ca released from the implant is considered safe [37]. While the Sr
content in the tissue was not measured, the amount of Sr released
from the pin, even in the event of a burst release, is much smaller
than the clinical therapeutic dose for Sr ranelate (5–20 mg per kilo per
day) [38].
Bone tissue mineral density appears to increase with time. Since
new bone is forming as the pin degrades, an increase in mineral density
valuewith time conﬁrmsmineralization of the new tissue. It is expected
that the mineral density is highest at the ﬁnal time point, as the tissue
had longer time to heal. Large scatter in the data at 1w and 3w is attrib-
uted to differences between animals, which are ampliﬁed at earlier time
points due to trauma from pin insertion and differences in pin
degradation.
Histology revealed few inﬂammatory cells andmild ﬁbrosis, as seen
at the early time points. This is expected post-surgery for an inert bio-
material and can be a sign of implant integration [39]. The few accumu-
lations of inﬂammatory cells that were observed around the alloy pins
were located around tissue cavities associatedwith gas formation, mak-
ing the inﬂammatory cells more prevalent at the 1w and 3w time
points. Bone resident cell inﬁltration was observed around all alloy im-
plants while the PLLA was surrounded by ﬁbrous tissue. The ﬁbrous
layer separating the bone and implant can be undesirable as it may
jeopardize implant stability, which can lead to ﬁxation failure [5,39]
and also prevent further implant degradation.
Osteoclast activity represents bone remodeling, which is naturally
occurring in bone tissue, but can also be an implication of implant
separation [40]. Osteoclasts were primarily located in the cortical region
and around tissue cavities. It is unclear if this trend is related to damage
and consecutive bone remodeling resulting from drilling and pin
insertion or a response to gas generation, or a combination of factors.
The current study investigates the in vivo response to the as-cast
Mg–1.0 wt.%Ca–0.5wt.%Sr alloy, with promising results. It is worth not-
ing, that properties of the material, such as degradation rate, can be tai-
lored by processing, alloying, coatings etc. [16,41,42], which may be
relevant for future studies towards clinical applications. In addition to
controlled degradation and biocompatibility, adequate strength of the
material is important clinically, to avoid failure of the implant. One of
the pins in the current study was found fractured upon dissection. Un-
fortunately the time of fracture is unknown, however it was still used
in the data analysis. The alloy's strength has been reported elsewhere
[16] by the authors.
5. Conclusions
This paper examines the in vivo local tissue response to a Mg–1.0
wt.%Ca–0.5wt.%Sr alloy for degradable implant orthopedic applications.
Despite early gas formation, the rat and local tissue responded reason-
ably well to the alloy implant with only a mild inﬂammatory response.
Cell inﬁltration was observed around the degrading implant, with new
bone replacing the implant as it degrades, with no histological evidence
of ﬁbrous encapsulation. In addition, mineralized bone was seen in the
cortical region after 6w, with regained bone mineral density. On the
contrary, PLLA biodegradable pins were intact at the end of the study
period and were surrounded by ﬁbrous tissue of varying thickness.
Overall, therewasminimal adverse host reaction, although an increased
osteoclast activity around implants was observed at the early stages,
which was attributed to tissue healing and bone remodeling. While
alloy biocompatibility in the rat was conﬁrmed, the effect of applied
stress on the degradation behavior, and its resultant effect on bone re-
modeling and strength has yet to be speciﬁcally investigated. Relevant
future investigations also include degradation studies determining the
effect of implant morphology and location in the body.
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